Switzerland debates dismantling its breast cancer
screening programme
Sophie Arie
A row has erupted in Switzerland ...
Upcoming SlideShare
Loading in …5

Screen breast cancer switzerland bmj 2014_Sophie Arie


Published on

Published in: Health & Medicine
  • Be the first to comment

  • Be the first to like this

No Downloads
Total views
On SlideShare
From Embeds
Number of Embeds
Embeds 0
No embeds

No notes for slide

Screen breast cancer switzerland bmj 2014_Sophie Arie

  1. 1. Switzerland debates dismantling its breast cancer screening programme Sophie Arie London A row has erupted in Switzerland after the Swiss Medical Board recommended that the country’s mammography screening programme for breast cancer be suspended because it leads to too many unnecessary interventions. In a report made public on 2 February, the board said that while systematic mammography screening for breast cancer saved 1-2 women’s lives for every 1000 screened, it led to unnecessary investigations and treatment for around 100 women in every 1000.1 “The desirable effect is offset by the undesirable effects,” said the report, which was based on study data from 1963 to 1991 comparing 1000 women who were screened with 1000 women who were not. The report also concluded that screening was not cost effective. The board was founded by the health ministers of the Swiss cantons, the Swiss Academy of Medical Sciences, the Swiss Medical Association, and the government of Lichtenstein in 2011 to offer independent expert medical advice. Its report recommended that no new systematic mammography screening programmes be introduced in Switzerland and a time limit be set on existing programmes. Leading cancer organisations in Switzerland strongly rejected the report, and it is not clear if any of its advice will lead to a change of policy. The Swiss Cancer League said it was “astonished” at the report, arguing that it was based on old data, its methodology was flawed, and it went against the global consensus, which is in favour of screening. “Like numerous national and international experts and organisations (WHO, EU), the Cancer League believes that the pros outweigh the cons,” the organisation said in a statement. Swiss Cancer Screening said that the report used exactly the same data that have led respected experts worldwide to reach the opposite conclusion. It criticised the board for questionable methodology, overemphasis on certain studies, and inaccurate calculations. In 2013 Switzerland adopted a national strategy against cancer, recommending systematic screening for women over 50. Eleven of the country’s 26 cantons have put screening programmes in place, some only within the last year. The Federal Public Health Office said it saw no reason to change that strategy but, it said, every effort must be made to improve the quality of mammography screening. Debate has grown in recent years over the benefits and disadvantages of breast cancer screening. The BMJ published a large Canadian study on 11 February, based on more recent data, that drew similar conclusions to those of the Swiss Medical Board.2 In the UK, the parliamentary Science and Technology Committee is reviewing the evidence underpinning all national screening programmes and is accepting submissions for the review up to 26 February.3 The Netherlands recently reviewed its screening programme and concluded, on 26 January, that the “advantages [of mammography screening] outweigh the disadvantages.”4 1 Swiss Medical Board. Systematic mammography screening. 15 Dec 2013. www.medical- board.ch/fileadmin/docs/public/mb/Fachberichte/2013-12-15_Bericht_Mammographie_ Final_Kurzfassung_e.pdf. 2 Miller AB, Wall C, Baines CJ, Sun P, To T, Narod SA. Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial. BMJ 2014;348:g366. 3 Wise J. MPs are to review evidence on screening programmes. BMJ 2013;347:f7557. 4 Health Council of the Netherlands. Population screening for breast cancer: expectations and developments. 2014. Publication no. 2014/01. www.gezondheidsraad.nl/sites/default/ files/summary_BV_Borstkanker_verwachtingen_en_ontwikkelingen_0.pdf. Cite this as: BMJ 2014;348:g1625 © BMJ Publishing Group Ltd 2014 For personal use only: See rights and reprints http://www.bmj.com/permissions Subscribe: http://www.bmj.com/subscribe BMJ 2014;348:g1625 doi: 10.1136/bmj.g1625 (Published 18 February 2014) Page 1 of 1 News NEWS